Navigation Links
DSM Receives European Outsourcing Awards for Carbon Footprint Reducing Technology
Date:10/7/2010

PARSIPPANY, N.J., Oct. 7 /PRNewswire/ -- DSM Pharmaceutical Products, the custom manufacturing organization of Royal DSM NV, is pleased to announce that their submission for the European Outsourcing Awards, organized by Via Media UK Ltd, entitled "Achieving substantial carbon dioxide footprint reduction for the scale up of a drug intermediate," was an award recipient at the 6th October ceremony held in Paris, France.  

DSM applied their InnoSyn™ route scouting services to launch a collaborative research program to identify a faster route for a drug intermediate using (bio)catalytic processes with the same level of reliability and quality, yet with a reduced carbon footprint of over fifty percent. The new process resulted also in shorter cycle times due to fewer steps in the process.

Andre de Vries, Ph.D., Competence Manager for Homogeneous Catalysis at DSM, commented, "This project involved scientists covering all relevant areas of organic process development, including biocatalysis and homogeneous catalysis. From the 10 new identified routes, all less than 5 steps, the route combining a biocatalytic and a metal-catalyzed step showed to be most sustainable. In this way, DSM as the contract manufacturer is contributing to extending the life cycle of the customer's product using innovation to decrease the eco footprint."

Dr. Kevin Robinson, Editorial Director, Pharma magazine and judging coordinator, stated: "The European Outsourcing Awards judging panel is selected to give an impartial, professional and wide-ranging level of expertise and is assembled exclusively from leading healthcare organisations and top business school academics." DSM was nominated under the categories of Most Improved Process, Plant or Facility, which focuses on expertise and innovation to meet customer requirements for time-to-market, and Best Contract Manufacturing Project, which focuses on production and commercial manufacturing innovation, cost-effectiveness and regulatory compliance.

Organized by Via Media UK Ltd in conjunction with Via Connect, a provider of various forums and events to the bio/pharmaceutical, nutraceutical and personal care industries, the European Outsourcing Awards gala dinner was held in Paris, France, during the week of the CPhI Worldwide trade event.

InnoSyn™ is a trademark of DSM

Via Media UK Ltd and Via Connect

Via Media UK Ltd is a dynamic media company that specialises in producing high quality publications - both printed and digital - for the supply chain, auto-ID, nutraceutical and functional food, pharmaceutical, biopharmaceutical and life science industries, including Pharma Magazine, which is distributed globally across the pharmaceutical, biopharmaceutical and life science industries with a focus on R&D, raw materials, packaging, manufacturing, QA/QC, business, management and marketing.

DSM Pharmaceutical Products

DSM Pharmaceutical Products is a global provider of high quality custom contract manufacturing and development services to the pharmaceutical and biopharmaceutical industries. DSM contract manufacturing services include: chemical development, registered intermediates, registered starting materials, active pharmaceutical ingredients (API's), mammalian cell production of monoclonal antibodies and proteins, formulation development, clinical trial manufacturing and finished dose form manufacturing of solids, semi-solids, and scheduled drugs, aseptic liquid and lyophilized products. More information: www.dsmpharmaceuticalproducts.com

DSM – the Life Sciences and Materials Sciences Company

Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about €8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com

For more information:

DSM Pharmaceutical Products
Guy Tiene
Director, Marketing and Communications
+1 973-257-8160
guy.tiene@dsm.com

DSM Innovative Synthesis BV, DSM Pharma Chemicals
Andre de Vries, Ph.D.
Competence Manager, Homogeneous Catalysis
+31 46 4761573
andre.vries-de@dsm.com



DSM Forward-looking statements

This press release contains forward-looking statements that involve inherent risks and uncertainties. These statements are based on current expectations, estimates and projections of the management of DSM and information currently available. The statements involve certain risks and uncertainties that are difficult to predict and therefore DSM does not guarantee that their expectations will be realized. Furthermore, DSM has no obligation to update the statements contained in this press release.


'/>"/>
SOURCE DSM Pharmaceutical Products
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DiFUSION Technologies Receives 510(k) Clearance of Xiphos™ Interbody Implants for Spinal Fusion
2. GenVec Receives Second-Year Funding From SAIC for HIV and Influenza Vaccine Development
3. Osseon Receives Second Patent Allowance for Minimally Invasive Vertebral Compression Fracture Treatment Devices
4. Prognosis Health Information Systems ChartAccess 4.0 Receives ONC-ATCB 2011/2012 Certification
5. Mylan Receives Approval for Fludarabine Phosphate Injection, USP
6. WATCHMAN® Receives German Reimbursement Coverage
7. Lingohocken Fire Company Receives PAD Donation After Recent Rescue at Fox Heath Farm
8. Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution
9. Advanced Life Sciences Receives $1.5 Million From Exercise of Unit Warrants and Secures Financing Commitment
10. China Shenghuo Receives Notice from NYSE Amex LLC Regarding Listing Standards
11. Progenika Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
Breaking Medicine News(10 mins):